Precigen, Inc. (PGEN)
6.94
+0.30
(+4.52%)
USD |
NASDAQ |
Oct 30, 16:00
5.27
-1.67
(-24.06%)
Pre-Market: 20:00
Precigen 30-Day Average Daily Volume : 5.111M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 5.111M |
| October 29, 2026 | 5.160M |
| October 28, 2026 | 5.214M |
| October 27, 2026 | 5.365M |
| October 26, 2026 | 5.332M |
| October 23, 2026 | 5.341M |
| October 22, 2026 | 5.265M |
| October 21, 2026 | 5.151M |
| October 20, 2026 | 5.057M |
| October 19, 2026 | 4.943M |
| October 16, 2026 | 4.878M |
| October 15, 2026 | 4.768M |
| October 14, 2026 | 4.724M |
| October 13, 2026 | 4.678M |
| October 12, 2026 | 4.736M |
| October 09, 2026 | 4.754M |
| October 08, 2026 | 4.807M |
| October 07, 2026 | 4.926M |
| October 06, 2026 | 4.983M |
| October 05, 2026 | 4.923M |
| October 02, 2026 | 4.728M |
| October 01, 2026 | 4.777M |
| September 30, 2026 | 4.895M |
| September 29, 2026 | 4.651M |
| September 28, 2026 | 4.722M |
| Date | Value |
|---|---|
| September 25, 2026 | 4.871M |
| September 24, 2026 | 4.837M |
| September 23, 2026 | 4.830M |
| September 22, 2026 | 4.807M |
| September 21, 2026 | 4.788M |
| September 18, 2026 | 4.872M |
| September 17, 2026 | 4.795M |
| September 16, 2026 | 5.048M |
| September 15, 2026 | 5.041M |
| September 14, 2026 | 5.196M |
| September 11, 2026 | 5.289M |
| September 10, 2026 | 5.340M |
| September 09, 2026 | 5.364M |
| September 08, 2026 | 5.385M |
| September 04, 2026 | 5.477M |
| September 03, 2026 | 5.500M |
| September 02, 2026 | 5.530M |
| September 01, 2026 | 5.543M |
| August 31, 2026 | 5.596M |
| August 28, 2026 | 5.574M |
| August 27, 2026 | 5.583M |
| August 26, 2026 | 5.549M |
| August 25, 2026 | 5.366M |
| August 24, 2026 | 5.268M |
| August 21, 2026 | 5.258M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Anika Therapeutics, Inc. | 102338.5 |
| Aldeyra Therapeutics, Inc. | 1.633M |
| Repligen Corp. | 1.401M |
| AC Immune SA | 206650.0 |
| Amgen, Inc. | 2.742M |